NCT04587115View on ClinicalTrials.gov

Reducing the Abuse Liability of Prescription Opioids

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 16, 2017

Primary Completion Date

June 1, 2019

Study Completion Date

January 1, 2020

Conditions
Addiction
Interventions
DRUG

Risperidone

Risperidone 1mg to be used in combination with other drugs

DRUG

Ziprasidone

Ziprasidone 80mg to be used in combination with other study drugs

DRUG

Oxycodone

Oxycodone alone in a capsule will be considered the control. Oxycodone 15 mg will also be used in combination with other study drugs

Trial Locations (1)

78229

Westgate Pain Clinic, San Antonio

All Listed Sponsors
lead

The University of Texas Health Science Center at San Antonio

OTHER

NCT04587115 - Reducing the Abuse Liability of Prescription Opioids | Biotech Hunter | Biotech Hunter